These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33039134)

  • 1. [Complementary and alternative medicine in cancer patients and randomized controlled trials].
    Murat-Ringot A; Preau M; Piriou V
    Bull Cancer; 2021 Jan; 108(1):102-116. PubMed ID: 33039134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Complementary and alternative medicines in cancer patients].
    Bosacki C; Vallard A; Gras M; Daguenet E; Morisson S; Méry B; Jmour O; Guy JB; Magné N
    Bull Cancer; 2019 May; 106(5):479-491. PubMed ID: 31023481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complementary and alternative medicine use in two French pediatric oncology centers: A common practice].
    Menut V; Seigneur E; Gras Leguen C; Orbach D; Thebaud E
    Bull Cancer; 2019 Mar; 106(3):189-200. PubMed ID: 30771881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. We and they in the house of healing: debate among Arab complementary medicine practitioners on an integrative versus alternative approach to supportive cancer care.
    Popper-Giveon A; Schiff E; Ben-Arye E
    Integr Cancer Ther; 2013 Nov; 12(6):488-95. PubMed ID: 23625026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of complementary and alternative medicine by cancer patients: systematic review].
    Spadacio C; Barros NF
    Rev Saude Publica; 2008 Feb; 42(1):158-64. PubMed ID: 18200356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementary and Alternative Medicine Treatments for Generalized Anxiety Disorder: Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Barić H; Đorđević V; Cerovečki I; Trkulja V
    Adv Ther; 2018 Mar; 35(3):261-288. PubMed ID: 29508154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complementary medicine in hemato-oncology care: review of controlled clinical studies].
    Ben-Arye E; Attias S; Shabbad E
    Harefuah; 2011 Aug; 150(8):664-7, 687, 686. PubMed ID: 21939121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a blended-learning training concept to train oncology physicians to advise their patients about complementary and integrative medicine (KOKON-KTO): study protocol for a prospective, multi-center, cluster-randomized trial.
    Helmer SM; Rogge AA; Fischer F; Pach D; Horneber M; Roll S; Witt CM
    Trials; 2019 Jan; 20(1):90. PubMed ID: 30696465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Homeopathy in cancer patients: What does the "best" evidence tell us?].
    de Nonneville A; Gonçalves A
    Bull Cancer; 2018 Apr; 105(4):426-430. PubMed ID: 29486922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methodological quality of patient-reported outcome research was low in complementary and alternative medicine in oncology.
    Efficace F; Horneber M; Lejeune S; Van Dam F; Leering S; Rottmann M; Aaronson NK
    J Clin Epidemiol; 2006 Dec; 59(12):1257-65. PubMed ID: 17098568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence and expectations of "alternative and complementary medicine" use during radiotherapy in 2016: A prospective study].
    Dupin C; Arsène-Henry A; Charleux T; Haaser T; Trouette R; Vendrely V
    Cancer Radiother; 2018 Oct; 22(6-7):682-687. PubMed ID: 30197027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental therapeutics: review of biologically based complementary and alternative medicine (CAM) therapies for potential application in children with cancer-part II.
    Melnick SJ
    J Pediatr Hematol Oncol; 2006 May; 28(5):271-85. PubMed ID: 16772876
    [No Abstract]   [Full Text] [Related]  

  • 13. A systematic review of complementary and alternative medicine interventions for the management of cancer-related fatigue.
    Finnegan-John J; Molassiotis A; Richardson A; Ream E
    Integr Cancer Ther; 2013 Jul; 12(4):276-90. PubMed ID: 23632236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of safety reporting for complementary and alternative therapies for dysmenorrhea.
    Kim SD
    Complement Ther Clin Pract; 2020 May; 39():101160. PubMed ID: 32379688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-based complementary oncology: innovative approaches to optimise standard therapy strategies.
    Beuth J
    Anticancer Res; 2010 May; 30(5):1767-71. PubMed ID: 20592376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary therapies: evaluating their effectiveness in cancer.
    Hilsden RJ; Verhoef MJ
    Patient Educ Couns; 1999 Oct; 38(2):101-8. PubMed ID: 14528702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence and effectiveness of complementary and alternative medicine: what has been learned and what it may be telling us about our patients, ourselves, and conventional medical treatment.
    Moyad MA
    Semin Urol Oncol; 2001 Nov; 19(4):257-69. PubMed ID: 11769878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. For randomized controlled trials, the quality of reports of complementary and alternative medicine was as good as reports of conventional medicine.
    Klassen TP; Pham B; Lawson ML; Moher D
    J Clin Epidemiol; 2005 Aug; 58(8):763-8. PubMed ID: 16018911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of complementary and alternative medicine for cancer.
    Kronenberg F; Mindes J; Jacobson JS
    Cancer Invest; 2005; 23(5):420-6. PubMed ID: 16193642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review: Complementary and alternative medicine in the irritable bowel syndrome.
    Hussain Z; Quigley EM
    Aliment Pharmacol Ther; 2006 Feb; 23(4):465-71. PubMed ID: 16441466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.